NRG Therapeutics
NRG Therapeutics36About
What does NRG Therapeutics do?
NRG Therapeutics is a biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's. Their approach centers on restoring mitochondrial function, a key factor in the progression of these debilitating conditions.
What is NRG Therapeutics's revenue?
StartupHub estimates NRG Therapeutics's annual revenue at $4.8M (range $2.7M to $11.5M, 65% confidence), based on comparable companies in the sector.
What is NRG Therapeutics's valuation?
StartupHub estimates NRG Therapeutics's effective valuation at $218.0M (range $146.5M to $351.6M, 19% confidence), based on comparable companies in the sector.
How much funding has NRG Therapeutics raised?
NRG Therapeutics has raised a total of $59M in funding. The most recent round on record is Series B.
Where is NRG Therapeutics headquartered?
NRG Therapeutics is headquartered in Stevenage, United Kingdom.
What industry does NRG Therapeutics operate in?
NRG Therapeutics operates in Biotech, MedTech, Drug Discovery, Neurodegenerative Diseases, Mitochondrial Dysfunction, Small Molecule Drugs.
How many employees does NRG Therapeutics have?
NRG Therapeutics has approximately 23 people on record.
No comments yet. Be the first to share your take.